Össur hf., together with its subsidiaries, engages in the design, development, production, and sale of non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company operates through two segments: Prosthetics and Bracing & Supports. The Prosthetics segment offers mechanical products, such as lower limb prosthetics and finger prostheses; and bionic products microprocessor-controlled feet, knees, hands, liners, fingers, and other components integrated with sensors, computing power, internal intelligence, and actuators for amputees. The Bracing & Supports segment provides bracing and supports products, such as supporting devices for spinal, knee, hip, foot, ankle, and hands that are primarily used to support joints and other body parts for therapeutic and preventative purposes; and injury solutions to enhance the healing process of fractures and ligament injuries. It serves specialized healthcare providers, including orthopedic and prosthetic clinics, hospitals, and surgery centers. The company sells its products through its direct sales networks and distributors. Össur hf. was incorporated in 1971 and is headquartered in Reykjavik, Iceland. Össur hf. is a subsidiary of William Demant Invest A/S.
According to Össur hf.'s latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.43. At the end of 2022 the company had a P/B ratio of 2.39.
Year | P/B ratio |
---|---|
2023 | 2.43 |
2022 | 2.39 |
2021 | 4.40 |
2020 | 0.88 |
2019 | 5.25 |
2018 | 3.70 |
2017 | 4.01 |
2016 | 4.35 |
2015 | 4.49 |
2014 | 4.79 |
2013 | 4.68 |